Core Laboratories (CLB) Competitors

Core Laboratories (NYSE:CLB) and Veren (NYSE:VRN) are both oils/energy companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, community ranking, institutional ownership, media sentiment, risk, valuation, earnings and dividends.

Which has more risk and volatility, CLB or VRN?

Core Laboratories has a beta of 2.38, indicating that its share price is 138% more volatile than the S&P 500. Comparatively, Veren has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500.

Is CLB or VRN a better dividend stock?

Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.2%. Veren pays an annual dividend of $0.33 per share and has a dividend yield of 6.6%. Core Laboratories pays out 6.1% of its earnings in the form of a dividend. Veren pays out 23.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Do analysts prefer CLB or VRN?

Core Laboratories currently has a consensus price target of $17.25, indicating a potential upside of 6.98%. Veren has a consensus price target of $12.67, indicating a potential upside of 153.08%. Given Veren's stronger consensus rating and higher probable upside, analysts clearly believe Veren is more favorable than Core Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Core Laboratories	2 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Veren	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33

Is CLB or VRN more profitable?

Veren has a net margin of 26.93% compared to Core Laboratories' net margin of 5.99%. Core Laboratories' return on equity of 16.24% beat Veren's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Core Laboratories	5.99%	16.24%	6.82%
Veren	26.93%	12.23%	6.80%

Do insiders & institutionals have more ownership in CLB or VRN?

97.8% of Core Laboratories shares are held by institutional investors. Comparatively, 49.4% of Veren shares are held by institutional investors. 0.8% of Core Laboratories shares are held by insiders. Comparatively, 0.3% of Veren shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community prefer CLB or VRN?

Core Laboratories received 465 more outperform votes than Veren when rated by MarketBeat users. However, 100.00% of users gave Veren an outperform vote while only 54.53% of users gave Core Laboratories an outperform vote.

Company	Underperform	Outperform
Core Laboratories	Outperform Votes 469 54.53%	Underperform Votes 391 45.47%
Veren	Outperform Votes 4 100.00%	Underperform Votes No Votes

Does the media refer more to CLB or VRN?

In the previous week, Core Laboratories had 2 more articles in the media than Veren. MarketBeat recorded 7 mentions for Core Laboratories and 5 mentions for Veren. Core Laboratories' average media sentiment score of 1.08 beat Veren's score of 0.72 indicating that Core Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Core Laboratories	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Veren	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better valuation and earnings, CLB or VRN?

Veren has higher revenue and earnings than Core Laboratories. Veren is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Core Laboratories	$523.85M	1.44	$31.40M	$0.66	24.43
Veren	$2.59B	1.18	$422.48M	$1.40	3.58

Summary

Core Laboratories beats Veren on 11 of the 21 factors compared between the two stocks.